NMPA-2021-0004-V104

Type IB variation for application NMPA-2021-0004. Type IB variation: Formulation Change for Glucovantib — critical change

Variation Number
NMPA-2021-0004-V104
Type
Type IB
Application
NMPA-2021-0004
Change
CHG-2021-0104
Status
Approved
Fee
€1,802
Submitted
2023-07-17
Approved
2024-04-21
Description

Type IB variation: Formulation Change for Glucovantib — critical change